AstraZeneca's Tezspire gets FDA approval for nasal polyp condition
Go back to AstraZeneca's Tezspire gets FDA approval for nasal polyp condition| Amgen Inc (NASDAQ: AMGN) | Delayed: 385.65 +5.87 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $379.78 | 52 Week High | $176.85 | |||
| Open | $378.51 | 52 Week Low | $133.64 | |||
| Day High | $386.50 | P/E | 58.08 | |||
| Day Low | $378.51 | EPS | $6.64 | |||
| Volume | 8,528,108 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,060,373 | |||||
